Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS.

Wenzhe FanJian GuoBowen ZhuShutong WangLei YuWanchang HuangHuishuang FanFuliang LiYanqin WuYue ZhaoYu WangMiao XueHongyu WangJiaping Li

Published in: European radiology (2021)

• DEB-TACE is safe and effective in HCC patients after a TIPS procedure. • DEB-TACE improves overall survival, objective response rate, and liver toxicities and is non-inferior to cTACE in terms of time to progression. • DEB-TACE might be a potential new therapeutic option for HCC patients with TIPS.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
minimally invasive
risk assessment
patient reported
climate change